Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects

NCT00759837 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Leukemia, Myeloid, Chronic

Interventions

DRUG: Bosutinib

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer